| Predictors of Hemoglobin Response to Eculizumab Therapy in Paroxysmal Nocturnal Hemoglobinuria. | |
| | |
MedLine Citation:
|
PMID: 23046169 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
BACKGROUND: Paroxysmal nocturnal hemoglobinuria is a clonal, hematopoietic stem cell disorder that manifests with hemolytic anemia and bone marrow failure. Eculizumab has been shown to improve anemia, decrease intravascular hemolysis and reduce the risk of thrombosis. DESIGN AND METHODS: This is a retrospective, single-center study of patients treated with Eculizumab and categorized according to response criteria. Complete response was defined as transfusion independence with normal hemoglobin for age/sex, absence of symptoms, and lactate dehydrogenase < 1.5 times the upper limit of normal. A good partial response was defined as decreased transfusions from pretreatment and lactate dehydrogenase <1.5 upper limit of normal without thrombosis. These patients did not achieve normal hemoglobins for age and sex. A suboptimal response was defined as unchanged transfusion needs and persistent of symptoms. RESULTS: Thirty patients with PNH clones were treated with eculizumab and classified as complete responders (4 patients), good partial responders (16) and suboptimal responders (10) over 863 patient-months of treatment. Complete responders had a decrease in red cell clone size while good partial responders had an increase. Thirteen patients treated did not meet inclusion criteria for the clinical trials of eculizumab due to lack of transfusions or thrombocytopenia; eight had at least a good partial response. CONCLUSIONS: Eculizumab is efficacious in patients with paroxysmal nocturnal hemoglobinuria, but responses can vary and may depend on underlying marrow failure, underlying inflammatory conditions and red cell clone size following treatment. Normalization of hemoglobin with decrease in red cell clone size may predict complete response. © 2012 John Wiley & Sons A/S. |
| | |
Authors:
|
Amy E Dezern; Donna Dorr; Robert A Brodsky |
Related Documents
:
|
15666259 - Prolonged gastric emptying half-time and gastric hypomotility after drug overdose. 8261829 - Intragastric distribution and gastric emptying of solids and liquids in functional dysp... 3526869 - Impaired contractile motility of the gallbladder after gastrectomy. 11217279 - A study of helicobacter pylori infection in patients with pernicious anemia. 21793729 - Clinical outcomes and contributors to weight loss in a cancer cachexia clinic. 16677159 - Clinical study of 31 patients with primary gastric mucosa-associated lymphoid tissue ly... 11054129 - Juvenile parkinsonism: a heterogeneous entity. 16700919 - Motion and twisting of magnetic particles ingested by alveolar macrophages in the human... 12637679 - Camera-based fdg pet and 67ga spect in evaluation of lymphoma: comparative study. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-10-10 |
Journal Detail:
|
Title: European journal of haematology Volume: - ISSN: 1600-0609 ISO Abbreviation: Eur. J. Haematol. Publication Date: 2012 Oct |
Date Detail:
|
Created Date: 2012-10-10 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8703985 Medline TA: Eur J Haematol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
© 2012 John Wiley & Sons A/S. |
Affiliation:
|
Division of Hematology, Department of Medicine, The Johns Hopkins School of Medicine. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The impact of metabolic syndrome on long-term outcomes of percutaneous nephrolithotomy (PCNL).
Next Document: Glycated Hemoglobin As a Predictor for Metabolic Syndrome in an Iranian Population with Normal Gluco...